UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000001509
Receipt number R000001821
Scientific Title Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
Date of disclosure of the study information 2008/11/16
Last modified on 2009/05/16 09:27:36

No. Disposal Last modified on Item of update
1 Insert 2008/11/16 22:14:22
2 Update 2009/05/16 09:27:36 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded